Abstract Background/Aim To define practical use and to specify the ideal method for
monitoring the liver toxicity of MTX in the management of psoriasis. Objective To …

Methotrexate is effective not only in treating psoriasis and rheumatoid arthritis but also
various other disorders. The use of methotrexate has been somewhat limited by concerns …

Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence
of psoriasis in Western industrialized countries ranges from 1.5% to 2%. Patients afflicted …

MTX is an immunosuppressant drug that occupies a key place in the management of many
autoimmune and inflammatory skin diseases. Although MTX has been widely prescribed in …

This compelling account of the author's experience with a chronic pain disorder and
subsequent interaction with the American health care system goes to the heart of the …

Psoriasis is a chronic, recurrent disease that affects between 1% and 3% of the population.
Patients with moderate to severe disease generally require phototherapy (eg narrowband …

Abstract Background and Aims: Hepatotoxicity, especially liver fibrosis, is the major concern
with long‐term,'low‐dose'oral methotrexate (MTX) therapy for psoriasis. The histological …

The review concluded that serial abnormal liver enzyme tests in rheumatoid arthritis patients
who took methotrexate might be associated with liver pathology, but that cirrhosis was …

Drugs used for treating inflammatory bowel disease are known to have a number of
gastrointestinal and liver adverse effects. 5-ASA products are relatively safe and have few …

Methotrexate (MTX), a stable derivative of aminopterin, is a folic acid antagonist that is
specific for the S phase cell cycle by inhibiting the enzyme, dihydrofolate reductase, which is …